Related Experiment Video
Updated: Feb 20, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Multiple-testing corrections in case-control studies using identity-by-descent segments
Seth D Temple1, Nicola H Chapman2, Seung Hoan Choi3
1Department of Statistics, University of Washington, Seattle, WA, USA; Department of Statistics, University of Michigan, Ann Arbor, MI, USA; Michigan Institute for Data and AI in Society, University of Michigan, Ann Arbor, MI, USA.
We developed a novel Identity-by-descent (IBD) mapping method to identify Alzheimer's disease (AD) risk loci. This approach complements genome-wide association studies (GWASs) and successfully detected six significant AD risk signals.
Area of Science:
- Genetics
- Genomic analysis
- Statistical genetics
Background:
- Genome-wide association studies (GWASs) may miss complex genetic signals from multiple causal variants.
- Identity-by-descent (IBD) mapping offers complementary insights into disease genetics.
Purpose of the Study:
- To introduce a novel IBD mapping statistic and hypothesis testing framework for identifying disease risk loci.
- To develop a scalable and reproducible computational workflow for IBD mapping.
- To apply the method to discover Alzheimer's disease (AD) risk loci.
Main Methods:
- Proposed a statistic based on the difference between affected-affected and control-control IBD rates.
- Utilized a computationally efficient stochastic process approach for genome-wide significance testing controlling the family-wise error rate (FWER).
- Integrated IBD mapping with selection scans and phenotype randomization for confounding assessment.
- Developed automated workflows for haplotype phasing and local ancestry probability calling.
Main Results:
- Whole-genome simulations confirmed conservative control of the FWER.
- Identified six genome-wide significant AD risk loci in the Alzheimer's Disease Sequencing Project (ADSP) data.
- Detected signals in samples of African, European, and Amish ancestries.
- Found previously associated variants and nominated therapeutic target genes within identified loci.
Conclusions:
- The developed IBD mapping approach is a scalable and effective tool for discovering disease risk loci, particularly for complex genetic architectures.
- This method enhances the utility of large genomic consortia data for understanding disease mechanisms.
- The identified AD risk loci provide further targets for therapeutic intervention and research.
Related Concept Videos
Test for Homogeneity
Hardy-Weinberg Principle
Multiple Allele Traits
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding in Epidemiological Studies
Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...

